The UK says it plans to keep its clinical trial regulations aligned with those of the EU during any Brexit transition period, and that even if the UK leaves without a deal it will put in place a “competitive” service for clinical trials with a “streamlined” parallel assessment service that delivers approvals within the same timeframes as the EU.
The pledge is made in a guidance document published by the government on what will happen in the life...